دورية أكاديمية
Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study
| العنوان: | Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study |
|---|---|
| المؤلفون: | Zhang, Bo, Liu, Hongyu, Shi, Chunlei, Gao, Zhiqiang, Zhong, RunboAff1, IDs12885024124790_cor5, Gu, Aiqin, Chu, Tianqing, Wang, Huimin, Xiong, Liwen, Zhang, Wei, Zhang, Xueyan, Yan, Bo, Teng, Jiajun, Wang, Weimin, Bai, Hao, Qiao, Rong, Cheng, Lei, Kuang, Yanbin, Zhao, Ruiying, Zhong, HuaAff1, IDs12885024124790_cor20, Han, BaohuiAff1, IDs12885024124790_cor21 |
| المصدر: | BMC Cancer. 24(1) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 14712407 |
|---|---|
| DOI: | 10.1186/s12885-024-12479-0 |